Regression of pathological cardiac hypertrophy: Signaling pathways and therapeutic targets

Pharmacology and Therapeutics

Volumn 135, Issue 3, 2012, Pages 337-354

  Hou, Jianglong ^a   Kang, Y James ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b University of Louisville School of Medicine   (United States)

Author keywords

Angiogenesis; HIF 1; LVADs; PKG 1; VEGF; VEGF receptors

Indexed keywords

CYCLIN DEPENDENT KINASE 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; HYPOXIA INDUCIBLE FACTOR 1; SILDENAFIL; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; APOPTOSIS; ARTICLE; AUTOPHAGY; BETA ADRENERGIC STIMULATION; CELL LOSS; CELL STRUCTURE; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; GENE EXPRESSION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84864451460     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.06.006     Document Type: Review

References (283)

1. E.D. Abel, and T. Doenst Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy Cardiovasc Res 90 2011 234 242
2. M.A. Acker Surgical therapies for heart failure J Card Fail 10 2004 S220 S224
3. T.W. Anderson, L.C. Neri, G.B. Schreiber, F.D. Talbot, and A. Zdrojewski Letter: ischemic heart disease, water hardness and myocardial magnesium Can Med Assoc J 113 1975 199 203
4. P. Anversa, C. Beghi, Y. Kikkawa, and G. Olivetti Myocardial infarction in rats. Infarct size, myocyte hypertrophy, and capillary growth Circ Res 58 1986 26 37
5. P. Anversa, A. Leri, and J. Kajstura Cardiac regeneration J Am Coll Cardiol 47 2006 1769 1776
6. J. Backs, T. Backs, S. Neef, M.M. Kreusser, L.H. Lehmann, and D.M. Patrick The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload Proc Natl Acad Sci U S A 106 2009 2342 2347
7. C.F. Baicu, J.D. Stroud, V.A. Livesay, E. Hapke, J. Holder, and F.G. Spinale Changes in extracellular collagen matrix alter myocardial systolic performance Am J Physiol Heart Circ Physiol 284 2003 H122 H132
8. J.L. Balligand, D. Ungureanu, R.A. Kelly, L. Kobzik, D. Pimental, and T. Michel Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium J Clin Invest 91 1993 2314 2319
9. A. Barbone, J.W. Holmes, P.M. Heerdt, A.H. The, Y. Naka, and N. Joshi Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling Circulation 104 2001 670 675
10. B. Bartling, H. Milting, H. Schumann, D. Darmer, L. Arusoglu, and M.M. Koerner Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure Circulation 100 1999 II216 II223
11. K.L. Baughman, and J.A. Jarcho Bridge to life - cardiac mechanical support N Engl J Med 357 2007 846 849
12. L.B. Becker, T.L. vanden Hoek, Z.H. Shao, C.Q. Li, and P.T. Schumacker Generation of superoxide in cardiomyocytes during ischemia before reperfusion Am J Physiol 277 1999 H2240 H2246
13. S.L. Belmonte, and B.C. Blaxall G protein coupled receptor kinases as therapeutic targets in cardiovascular disease Circ Res 109 2011 309 319
14. A.P. Beltrami, L. Barlucchi, D. Torella, M. Baker, F. Limana, and S. Chimenti Adult cardiac stem cells are multipotent and support myocardial regeneration Cell 114 2003 763 776
15. K. Berenji, M.H. Drazner, B.A. Rothermel, and J.A. Hill Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol 289 2005 H8 H16
16. R.J. Bick, A.M. Grigore, B.J. Poindexter, P.M. Schnee, N.A. Nussmeier, and I.D. Gregoric Left ventricular unloading with an assist device results in receptor relocalization as well as increased beta-adrenergic receptor numbers: are these changes indications for outcome? J Card Surg 20 2005 332 336
17. K.A. Bicknell, C.H. Coxon, and G. Brooks Can the cardiomyocyte cell cycle be reprogrammed? J Mol Cell Cardiol 42 2007 706 721
18. E.J. Birks, R.S. George, M. Hedger, T. Bahrami, P. Wilton, and C.T. Bowles Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study Circulation 123 2011 381 390
19. 31P NMR magnetization transfer study J Biol Chem 260 1985 3512 3517
20. E.D. Blume, D.C. Naftel, H.J. Bastardi, B.W. Duncan, J.K. Kirklin, and S.A. Webber Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study Circulation 113 2006 2313 2319
21. G. Borkow, J. Gabbay, R. Dardik, A.I. Eidelman, Y. Lavie, and Y. Grunfeld Molecular mechanisms of enhanced wound healing by copper oxide-impregnated dressings Wound Repair Regen 18 2010 266 275
22. A.J. Boyle, D.D. Ascheim, M.J. Russo, R.L. Kormos, R. John, and Y. Naka Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification J Heart Lung Transplant 30 2011 402 407
23. N.R. Brady, A. Hamacher-Brady, and R.A. Gottlieb Proapoptotic BCL-2 family members and mitochondrial dysfunction during ischemia/reperfusion injury, a study employing cardiac HL-1 cells and GFP biosensors Biochim Biophys Acta 1757 2006 667 678
24. N.R. Brady, A. Hamacher-Brady, H. Yuan, and R.A. Gottlieb The autophagic response to nutrient deprivation in the hl-1 cardiac myocyte is modulated by Bcl-2 and sarco/endoplasmic reticulum calcium stores FEBS J 274 2007 3184 3197
25. A.J. Brady, J.B. Warren, P.A. Poole-Wilson, T.J. Williams, and S.E. Harding Nitric oxide attenuates cardiac myocyte contraction Am J Physiol 265 1993 H176 H182
26. C.G. Brilla, and B. Maisch Regulation of the structural remodelling of the myocardium: from hypertrophy to heart failure Eur Heart J 15 Suppl. D 1994 45 52
27. B.A. Bruckner, S.J. Stetson, A. Perez-Verdia, K.A. Youker, B. Radovancevic, and J.H. Connelly Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support J Heart Lung Transplant 20 2001 457 464
28. L.M. Buja, and D. Vela Cardiomyocyte death and renewal in the normal and diseased heart Cardiovasc Pathol 17 2008 349 374
29. M. Bujak, and N.G. Frangogiannis The role of TGF-beta signaling in myocardial infarction and cardiac remodeling Cardiovasc Res 74 2007 184 195
30. J. Cai, F.F. Yi, Z.Y. Bian, D.F. Shen, L. Yang, and L. Yan Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway J Cell Mol Med 13 2009 909 925
31. A. Care, D. Catalucci, F. Felicetti, D. Bonci, A. Addario, and P. Gallo MicroRNA-133 controls cardiac hypertrophy Nat Med 13 2007 613 618
32. J.F. Carroll, and S.C. Tyagi Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit Am J Hypertens 18 2005 692 698
33. K. Chatterjee Neurohormonal activation in congestive heart failure and the role of vasopressin Am J Cardiol 95 2005 8B 13B
34. Y. Chen, M.B. Azad, and S.B. Gibson Superoxide is the major reactive oxygen species regulating autophagy Cell Death Differ 16 2009 1040 1052
35. Y. Chen, E. McMillan-Ward, J. Kong, S.J. Israels, and S.B. Gibson Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species J Cell Sci 120 2007 4155 4166
36. K. Chiba, S. Moriyama, Y. Ishigai, A. Fukuzawa, K. Irie, and T. Shibano Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery Br J Pharmacol 112 1994 837 842
37. B. Chipperfield, and J.R. Chipperfield Differences in metal content of the heart muscle in death from ischemic heart disease Am Heart J 95 1978 732 737
38. D.E. Clark, S.K. Smith, Y. He, K.A. Day, D.R. Licence, and A.N. Corps A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation Biol Reprod 59 1998 1540 1548
39. J.P. Cleutjens The role of matrix metalloproteinases in heart disease Cardiovasc Res 32 1996 816 821
40. J.P. Cleutjens, and E.E. Creemers Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction J Card Fail 8 2002 S344 S348
41. M. Dandel, Y. Weng, H. Siniawski, E. Potapov, H.B. Lehmkuhl, and R. Hetzer Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices Circulation 112 2005 I37 I45
42. D.F. Davila, T.J. Nunez, R. Odreman, and C.A. de Davila Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications Int J Cardiol 101 2005 343 346
43. N.V. Davydenko, I.P. Smirnova, E.A. Kvasha, and I.M. Gorbas The relationship between the copper and zinc intake with food and the prevalence of ischemic heart disease and its risk factors Lik Sprava 1995 73 77
44. C. de Vries, J.A. Escobedo, H. Ueno, K. Houck, N. Ferrara, and L.T. Williams The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor Science 255 1992 989 991
45. A.M. deCathelineau, and P.M. Henson The final step in programmed cell death: phagocytes carry apoptotic cells to the grave Essays Biochem 39 2003 105 117
46. J. Diez, B. Lopez, A. Gonzalez, and R. Querejeta Clinical aspects of hypertensive myocardial fibrosis Curr Opin Cardiol 16 2001 328 335
47. K. Dipla, J.A. Mattiello, V. Jeevanandam, S.R. Houser, and K.B. Margulies Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure Circulation 97 1998 2316 2322
48. R.S. Eliot, F.C. Clayton, G.M. Pieper, and G.L. Todd Influence of environmental stress on pathogenesis of sudden cardiac death Fed Proc 36 1977 1719 1724
49. L. Elsherif, Y. Jiang, J.T. Saari, and Y.J. Kang Dietary copper restriction-induced changes in myocardial gene expression and the effect of copper repletion Exp Biol Med (Maywood) 229 2004 616 622
50. L. Elsherif, R.V. Ortines, J.T. Saari, and Y.J. Kang Congestive heart failure in copper-deficient mice Exp Biol Med (Maywood) 228 2003 811 817
51. L. Elsherif, L. Wang, J.T. Saari, and Y.J. Kang Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice J Nutr 134 2004 855 860
52. 2+ Am J Physiol Heart Circ Physiol 279 2000 H2713 H2719
53. J.W. Entwistle III Short- and long-term mechanical ventricular assistance towards myocardial recovery Surg Clin North Am 84 2004 201 221
54. W. Feng, F. Ye, W. Xue, Z. Zhou, and Y.J. Kang Copper regulation of hypoxia-inducible factor-1 activity Mol Pharmacol 75 2009 174 182
55. B. Fiedler, S.M. Lohmann, A. Smolenski, S. Linnemuller, B. Pieske, and F. Schroder Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes Proc Natl Acad Sci U S A 99 2002 11363 11368
56. M.F. Flanagan, A.M. Fujii, S.D. Colan, R.G. Flanagan, and J.E. Lock Myocardial angiogenesis and coronary perfusion in left ventricular pressure-overload hypertrophy in the young lamb. Evidence for inhibition with chronic protamine administration Circ Res 68 1991 1458 1470
57. M. Flesch, K.B. Margulies, H.C. Mochmann, D. Engel, N. Sivasubramanian, and D.L. Mann Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading Circulation 104 2001 2273 2276
58. O.H. Frazier First use of an untethered, vented electric left ventricular assist device for long-term support Circulation 89 1994 2908 2914
59. O.H. Frazier, C.R. Benedict, B. Radovancevic, R.J. Bick, P. Capek, and W.E. Springer Improved left ventricular function after chronic left ventricular unloading Ann Thorac Surg 62 1996 675 681 (discussion 681-682)
60. X.M. Gao, H. Kiriazis, X.L. Moore, X.H. Feng, K. Sheppard, and A. Dart Regression of pressure overload-induced left ventricular hypertrophy in mice Am J Physiol Heart Circ Physiol 288 2005 H2702 H2707
61. S.J. Gardai, K.A. McPhillips, S.C. Frasch, W.J. Janssen, A. Starefeldt, and J.E. Murphy-Ullrich Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte Cell 123 2005 321 334
62. S. Gaspar-Pereira, N. Fullard, P.A. Townsend, P.S. Banks, E.L. Ellis, and C. Fox The NF-kappaB subunit c-Rel stimulates cardiac hypertrophy and fibrosis Am J Pathol 180 2011 929 939
63. A. Gonzalez, B. Lopez, R. Querejeta, and J. Diez Regulation of myocardial fibrillar collagen by angiotensin II. A role in hypertensive heart disease? J Mol Cell Cardiol 34 2002 1585 1593
64. R.A. Gottlieb, K.O. Burleson, R.A. Kloner, B.M. Babior, and R.L. Engler Reperfusion injury induces apoptosis in rabbit cardiomyocytes J Clin Invest 94 1994 1621 1628
65. R.A. Gottlieb, K.D. Finley, and R.M. Mentzer Jr. Cardioprotection requires taking out the trash Basic Res Cardiol 104 2009 169 180
66. D.B. Gray, L. Polo-Parada, G.R. Pilar, P. Eang, R.R. Metzger, and E. Klann A nitric oxide/cyclic GMP-dependent protein kinase pathway alters transmitter release and inhibition by somatostatin at a site downstream of calcium entry J Neurochem 72 1999 1981 1990
67. D.J. Grieve, P.A. MacCarthy, N.P. Gall, A.C. Cave, and A.M. Shah Divergent biological actions of coronary endothelial nitric oxide during progression of cardiac hypertrophy Hypertension 38 2001 267 273
68. A.B. Gustafsson, and R.A. Gottlieb Autophagy in ischemic heart disease Circ Res 104 2009 150 158
69. H. Haddad, W. Elabbassi, S. Moustafa, R. Davies, T. Mesana, and P. Hendry Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension ASAIO J 51 2005 456 460
70. A.P. Halestrap, S.J. Clarke, and S.A. Javadov Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection Cardiovasc Res 61 2004 372 385
71. A. Hamacher-Brady, N.R. Brady, and R.A. Gottlieb Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes J Biol Chem 281 2006 29776 29787
72. S. Hamasaki, J. Al Suwaidi, S.T. Higano, K. Miyauchi, D.R. Holmes Jr., and A. Lerman Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy J Am Coll Cardiol 35 2000 1654 1660
73. M. Harada, Y. Takeishi, T. Arimoto, T. Niizeki, T. Kitahara, and K. Goto Diacylglycerol kinase zeta attenuates pressure overload-induced cardiac hypertrophy Circ J 71 2007 276 282
74. J.D. Harding, V. Piacentino III, J.P. Gaughan, S.R. Houser, and K.B. Margulies Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure Circulation 104 2001 1241 1247
75. W. He, and Y.J. Kang Ischemia-induced copper loss and suppression of angiogenesis in the pathogenesis of myocardial infarction Cardiovasc Toxicol 2012 (Published online 29 May 2012). http://dx.doi.org/10.1007/s12012-012-9174-y
76. P.M. Heerdt, J.W. Holmes, B. Cai, A. Barbone, J.D. Madigan, and S. Reiken Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure Circulation 102 2000 2713 2719
77. J. Heineke, M. Auger-Messier, R.N. Correll, J. Xu, M.J. Benard, and W. Yuan CIB1 is a regulator of pathological cardiac hypertrophy Nat Med 16 2010 872 879
78. C.S. Herrington, and A.E. Tsirka Pediatric cardiac transplantation Semin Thorac Cardiovasc Surg 16 2004 404 409
79. Y. Higashikuni, J. Sainz, K. Nakamura, M. Takaoka, S. Enomoto, and H. Iwata The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response Arterioscler Thromb Vasc Biol 32 2011 654 661
80. M. Hirsila, P. Koivunen, L. Xu, T. Seeley, K.I. Kivirikko, and J. Myllyharju Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway FASEB J 19 2005 1308 1310
81. A. Hoeben, B. Landuyt, M.S. Highley, H. Wildiers, A.T. Van Oosterom, and E.A. De Bruijn Vascular endothelial growth factor and angiogenesis Pharmacol Rev 56 2004 549 580
82. R. Holtwick, M. van Eickels, B.V. Skryabin, H.A. Baba, A. Bubikat, and F. Begrow Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A J Clin Invest 111 2003 1399 1407
83. J.K.F. Hon, and M.H. Yacoub Bridge to recovery with the use of left ventricular assist device and clenbuterol Ann Thorac Surg 75 2003 S36 S41
84. M. Hoyer-Hansen, L. Bastholm, P. Szyniarowski, M. Campanella, G. Szabadkai, and T. Farkas Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2 Mol Cell 25 2007 193 205
85. 2-dependent degradation domain via the ubiquitin-proteasome pathway Proc Natl Acad Sci U S A 95 1998 7987 7992
86. Y. Huang, R.P. Hickey, J.L. Yeh, D. Liu, A. Dadak, and L.H. Young Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart FASEB J 18 2004 1138 1140
87. Y. Huang, S.N. Hunyor, L. Jiang, O. Kawaguchi, K. Shirota, and Y. Ikeda Remodeling of the chronic severely failing ischemic sheep heart after coronary microembolization: functional, energetic, structural, and cellular responses Am J Physiol Heart Circ Physiol 286 2004 H2141 H2150
88. O. Hudlicka, M. Brown, and S. Egginton Angiogenesis in skeletal and cardiac muscle Physiol Rev 72 1992 369 417
89. G.C. Hughes, S.S. Biswas, B. Yin, R.E. Coleman, T.R. DeGrado, and C.K. Landolfo Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF Ann Thorac Surg 77 2004 812 818
90. Y. Huo, C.O. Linares, and G.S. Kassab Capillary perfusion and wall shear stress are restored in the coronary circulation of hypertrophic right ventricle Circ Res 100 2007 273 283
91. J.M. Huss, and D.P. Kelly Mitochondrial energy metabolism in heart failure: a question of balance J Clin Invest 115 2005 547 555
92. J.S. Ingwall, M.F. Kramer, M.A. Fifer, B.H. Lorell, R. Shemin, and W. Grossman The creatine kinase system in normal and diseased human myocardium N Engl J Med 313 1985 1050 1054
93. J.S. Ingwall, and R.G. Weiss Is the failing heart energy starved? On using chemical energy to support cardiac function Circ Res 95 2004 135 145
94. K. Inoki, M.N. Corradetti, and K.L. Guan Dysregulation of the TSC-mTOR pathway in human disease Nat Genet 37 2005 19 24
95. Y. Ishigai, T. Mori, T. Ikeda, A. Fukuzawa, and T. Shibano Role of bradykinin-NO pathway in prevention of cardiac hypertrophy by ACE inhibitor in rat cardiomyocytes Am J Physiol 273 1997 H2659 H2663
96. 2 sensing Science 292 2001 464 468
97. Y. Izumiya, I. Shiojima, K. Sato, D.B. Sawyer, W.S. Colucci, and K. Walsh Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload Hypertension 47 2006 887 893
98. 2-regulated prolyl hydroxylation Science 292 2001 468 472
99. S. Janssens, P. Pokreisz, L. Schoonjans, M. Pellens, P. Vermeersch, and M. Tjwa Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction Circ Res 94 2004 1256 1262
100. Y. Jiang, C. Reynolds, C. Xiao, W. Feng, Z. Zhou, and W. Rodriguez Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice J Exp Med 204 2007 657 666
101. J. Kajstura, W. Cheng, K. Reiss, W.A. Clark, E.H. Sonnenblick, and S. Krajewski Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats Lab Invest 74 1996 86 107
102. Y. Kakinuma, T. Miyauchi, K. Yuki, N. Murakoshi, K. Goto, and I. Yamaguchi Novel molecular mechanism of increased myocardial endothelin-1 expression in the failing heart involving the transcriptional factor hypoxia-inducible factor-1alpha induced for impaired myocardial energy metabolism Circulation 103 2001 2387 2394
103. S.A. Kamath, S.R. Laskar, and C.W. Yancy Novel therapies for heart failure: vasopressin and selective aldosterone antagonists Congest Heart Fail 11 2005 21 29
104. Y.J. Kang, Z.X. Zhou, H. Wu, G.W. Wang, J.T. Saari, and J.B. Klein Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide Lab Invest 80 2000 745 757
105. R. Karch, F. Neumann, R. Ullrich, J. Neumuller, B.K. Podesser, and M. Neumann The spatial pattern of coronary capillaries in patients with dilated, ischemic, or inflammatory cardiomyopathy Cardiovasc Pathol 14 2005 135 144
106. T. Karpanen, M. Bry, H.M. Ollila, T. Seppanen-Laakso, E. Liimatta, and H. Leskinen Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy Circ Res 103 2008 1018 1026
107. G.S. Kassab, K. Imoto, F.C. White, C.A. Rider, Y.C. Fung, and C.M. Bloor Coronary arterial tree remodeling in right ventricular hypertrophy Am J Physiol 265 1993 H366 H375
108. G.S. Kassab, A. Schatz, K. Imoto, and Y.C. Fung Remodeling of the bifurcation asymmetry of right coronary ventricular branches in hypertrophy Ann Biomed Eng 28 2000 424 430
109. D. Kaye, and M. Esler Sympathetic neuronal regulation of the heart in aging and heart failure Cardiovasc Res 66 2005 256 264
110. Q. Ke, T. Kluz, and M. Costa Down-regulation of the expression of the FIH-1 and ARD-1 genes at the transcriptional level by nickel and cobalt in the human lung adenocarcinoma A549 cell line Int J Environ Res Public Health 2 2005 10 13
111. R. Khan, and R. Sheppard Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia Immunology 118 2006 10 24
112. A.R. Kherani, and M.C. Oz Ventricular assistance to bridge to transplantation Surg Clin North Am 84 2004 75 89 (viii-ix)
113. H. Kinoshita, K. Kuwahara, M. Nishida, Z. Jian, X. Rong, and S. Kiyonaka Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart Circ Res 106 2010 1849 1860
114. M. Kinoshita, H. Takano, S. Takaichi, Y. Taenaka, and T. Nakatani Influence of prolonged ventricular assistance on myocardial histopathology in intact heart Ann Thorac Surg 61 1996 640 645
115. L.M. Klevay Ischemic heart disease as copper deficiency Adv Exp Med Biol 258 1989 197 208
116. S. Kliche, and J. Waltenberger VEGF receptor signaling and endothelial function IUBMB Life 52 2001 61 66
117. D.J. Klionsky, and S.D. Emr Autophagy as a regulated pathway of cellular degradation Science 290 2000 1717 1721
118. S. Klotz, A.H. Jan Danser, and D. Burkhoff Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process Prog Biophys Mol Biol 97 2008 479 496
119. N. Koitabashi, T. Aiba, G.G. Hesketh, J. Rowell, M. Zhang, and E. Takimoto Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition J Mol Cell Cardiol 48 2010 713 724
120. S. Koneru, S. Varma Penumathsa, M. Thirunavukkarasu, R. Vidavalur, L. Zhan, and P.K. Singal Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1 J Cell Mol Med 12 2008 2651 2664
121. J. Kotera, K.A. Grimes, J.D. Corbin, and S.H. Francis cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5 Biochem J 372 2003 419 426
122. L.A. Kubasiak, O.M. Hernandez, N.H. Bishopric, and K.A. Webster Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3 Proc Natl Acad Sci U S A 99 2002 12825 12830
123. C. Kugler, D. Malehsa, U. Tegtbur, E. Guetzlaff, A.L. Meyer, and C. Bara Health-related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices: a prospective, comparative study J Heart Lung Transplant 30 2011 204 210
124. M. Kukucka, E. Potapov, A. Stepanenko, K. Weller, A. Mladenow, and H. Kuppe Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: effect of nitric oxide inhalation J Thorac Cardiovasc Surg 141 2011 1009 1014
125. A. Kuma, M. Hatano, M. Matsui, A. Yamamoto, H. Nakaya, and T. Yoshimori The role of autophagy during the early neonatal starvation period Nature 432 2004 1032 1036
126. K. Kyosola Mitochondrial injury and autophagocytosis within the myocardial cell after the cold ischaemic anoxic asystole Scand J Thorac Cardiovasc Surg 15 1981 83 85
127. S.H. Lee, P.L. Wolf, R. Escudero, R. Deutsch, S.W. Jamieson, and P.A. Thistlethwaite Early expression of angiogenesis factors in acute myocardial ischemia and infarction N Engl J Med 342 2000 626 633
128. M. Leist, B. Single, A.F. Castoldi, S. Kuhnle, and P. Nicotera Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis J Exp Med 185 1997 1481 1486
129. A. Leri, J. Kajstura, and P. Anversa Cardiac stem cells and mechanisms of myocardial regeneration Physiol Rev 85 2005 1373 1416
130. B. Levine, and D.J. Klionsky Development by self-digestion: molecular mechanisms and biological functions of autophagy Dev Cell 6 2004 463 477
131. Y.Y. Li, Y. Feng, C.F. McTiernan, W. Pei, C.S. Moravec, and P. Wang Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices Circulation 104 2001 1147 1152
132. H.L. Li, C. Liu, G. de Couto, M. Ouzounian, M. Sun, and A.B. Wang Curcumin prevents and reverses murine cardiac hypertrophy J Clin Invest 118 2008 879 893
133. J.R. Libonati Cardiac remodeling and function following exercise and angiotensin II receptor antagonism Eur J Appl Physiol 2011 (Published online 6 December 2011). http://dx.doi.org/10.1007/s00421-011-2263-y
134. M. Loebe, J. Muller, and R. Hetzer Ventricular assistance for recovery of cardiac failure Curr Opin Cardiol 14 1999 234 248
135. D.W. Losordo, P.R. Vale, J.F. Symes, C.H. Dunnington, D.D. Esakof, and M. Maysky Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia Circulation 98 1998 2800 2804
136. 2+ entry is required for pathological cardiac hypertrophy J Mol Cell Cardiol 52 2012 136 147
137. J.D. Madigan, A. Barbone, A.F. Choudhri, D.L. Morales, B. Cai, and M.C. Oz Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device J Thorac Cardiovasc Surg 121 2001 902 908
138. R. Madonna, and R. De Caterina VEGF receptor switching in heart development and disease Cardiovasc Res 84 2009 4 6
139. A. Makino, J. Suarez, H. Wang, D.D. Belke, B.T. Scott, and W.H. Dillmann Thyroid hormone receptor-beta is associated with coronary angiogenesis during pathological cardiac hypertrophy Endocrinology 150 2009 2008 2015
140. D.M. Mancini, A. Beniaminovitz, H. Levin, K. Catanese, M. Flannery, and M. DiTullio Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure Circulation 98 1998 2383 2389
141. F. Martin, T. Linden, D.M. Katschinski, F. Oehme, I. Flamme, and C.K. Mukhopadhyay Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation Blood 105 2005 4613 4619
142. B.M. Massie LVADs as long-term cardiac replacement: success but on what terms and at what cost? J Card Fail 8 2002 61 62
143. N. Masson, C. Willam, P.H. Maxwell, C.W. Pugh, and P.J. Ratcliffe Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation EMBO J 20 2001 5197 5206
144. P. Maxwell, and K. Salnikow HIF-1: an oxygen and metal responsive transcription factor Cancer Biol Ther 3 2004 29 35
145. P.H. Maxwell, M.S. Wiesener, G.W. Chang, S.C. Clifford, E.C. Vaux, and M.E. Cockman The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 1999 271 275
146. S. Maybaum, D. Mancini, S. Xydas, R.C. Starling, K. Aaronson, and F.D. Pagani Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group Circulation 115 2007 2497 2505
147. P.M. McCarthy, S. Nakatani, R. Vargo, K. Kottke-Marchant, H. Harasaki, and K.B. James Structural and left ventricular histologic changes after implantable LVAD insertion Ann Thorac Surg 59 1995 609 613
148. P.M. McKie, A. Cataliotti, B.D. Lahr, F.L. Martin, M.M. Redfield, and K.R. Bailey The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects J Am Coll Cardiol 55 2010 2140 2147
149. T.A. McKinsey, and D.A. Kass Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface Nat Rev Drug Discov 6 2007 617 635
150. T.J. Meine, and S.D. Russell A history of orthotopic heart transplantation Cardiol Rev 13 2005 190 196
151. P. Melgar-Lesmes, S. Tugues, J. Ros, G. Fernandez-Varo, M. Morales-Ruiz, and J. Rodes Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats Gut 58 2009 285 292
152. C. Mihl, W.R. Dassen, and H. Kuipers Cardiac remodelling: concentric versus eccentric hypertrophy in strength and endurance athletes Neth Heart J 16 2008 129 133
153. B. Millauer, S. Wizigmann-Voos, H. Schnurch, R. Martinez, N.P. Moller, and W. Risau High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis Cell 72 1993 835 846
154. T. Minamino, and M. Kitakaze ER stress in cardiovascular disease J Mol Cell Cardiol 48 2010 1105 1110
155. A.L. Moens, E. Takimoto, C.G. Tocchetti, K. Chakir, D. Bedja, and G. Cormaci Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy Circulation 117 2008 2626 2636
156. D. Mukherjee Current clinical perspectives on myocardial angiogenesis Mol Cell Biochem 264 2004 157 167
157. J. Muller, G. Wallukat, Y.G. Weng, M. Dandel, S. Spiegelsberger, and S. Semrau Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy Circulation 96 1997 542 549
158. T. Murohara, T. Asahara, M. Silver, C. Bauters, H. Masuda, and C. Kalka Nitric oxide synthase modulates angiogenesis in response to tissue ischemia J Clin Invest 101 1998 2567 2578
159. B. Nadal-Ginard, J. Kajstura, P. Anversa, and A. Leri A matter of life and death: cardiac myocyte apoptosis and regeneration J Clin Invest 111 2003 1457 1459
160. T. Nagayama, S. Hsu, M. Zhang, N. Koitabashi, D. Bedja, and K.L. Gabrielson Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload J Am Coll Cardiol 53 2009 207 215
161. A. Nakai, O. Yamaguchi, T. Takeda, Y. Higuchi, S. Hikoso, and M. Taniike The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress Nat Med 13 2007 619 624
162. H.W. Nemeh, and N.G. Smedira Mechanical treatment of heart failure: the growing role of LVADs and artificial hearts Cleve Clin J Med 70 2003 223 226 (229-233)
163. +-creatine cotransporter in failing human myocardium and in experimental heart failure Circulation 100 1999 1847 1850
164. J. Nishi, T. Minamino, H. Miyauchi, A. Nojima, K. Tateno, and S. Okada Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt Circ Res 103 2008 261 268
165. T. Nishikimi, J.R. Hagaman, N. Takahashi, H.S. Kim, H. Matsuoka, and O. Smithies Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene Cardiovasc Res 66 2005 94 103
166. M.L. Ogletree-Hughes, L.B. Stull, W.E. Sweet, N.G. Smedira, P.M. McCarthy, and C.S. Moravec Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart
167. M. Ohh, C.W. Park, M. Ivan, M.A. Hoffman, T.Y. Kim, and L.E. Huang Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein Nat Cell Biol 2 2000 423 427
168. S. Ohtomo, M. Nangaku, Y. Izuhara, S. Takizawa, C.Y. Strihou, and T. Miyata Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model Nephrol Dial Transplant 23 2008 1166 1172
169. G. Olivetti, R. Abbi, F. Quaini, J. Kajstura, W. Cheng, and J.A. Nitahara Apoptosis in the failing human heart N Engl J Med 336 1997 1131 1141
170. R.G. O'Neil VASP: a TRPC4-associated phosphoprotein that mediates PKG-induced inhibition of store-operated calcium influx Am J Physiol Renal Physiol 293 2007 F1766 F1767
171. O.S. Opgaard, and P.H. Wang IGF-I is a matter of heart Growth Horm IGF Res 15 2005 89 94
172. L.H. Opie, P.J. Commerford, B.J. Gersh, and M.A. Pfeffer Controversies in ventricular remodelling Lancet 367 2006 356 367
173. M. Paillard, L. Gomez, L. Augeul, J. Loufouat, E.J. Lesnefsky, and M. Ovize Postconditioning inhibits mPTP opening independent of oxidative phosphorylation and membrane potential J Mol Cell Cardiol 46 2009 902 909
174. S.V. Pamboukian, J.A. Tallaj, R.N. Brown, W.L. Holman, M. Blood, and J.F. George Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol J Heart Lung Transplant 30 2011 879 887
175. J.Y. Park, W. Li, D. Zheng, P. Zhai, Y. Zhao, and T. Matsuda Comparative analysis of mRNA isoform expression in cardiac hypertrophy and development reveals multiple post-transcriptional regulatory modules PLoS One 6 2011 e22391
176. E. Pasini, A. Cargnioni, F. Pastore, R. Razzetti, S. Bongrani, and G.L. Gitti Effect of nolomirole on monocrotaline-induced heart failure Pharmacol Res 49 2004 1 5
177. J.D. Pearlman, M.G. Hibberd, M.L. Chuang, K. Harada, J.J. Lopez, and S.R. Gladstone Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis Nat Med 1 1995 1085 1089
178. V. Pelouch, I.M. Dixon, L. Golfman, R.E. Beamish, and N.S. Dhalla Role of extracellular matrix proteins in heart function Mol Cell Biochem 129 1993 101 120
179. Z.B. Popovic, U.N. Khot, G.M. Novaro, F. Casas, N.L. Greenberg, and M.J. Garcia Effects of sodium nitroprusside in aortic stenosis associated with severe heart failure: pressure-volume loop analysis using a numerical model Am J Physiol Heart Circ Physiol 288 2005 H416 H423
180. X. Qi, A. Vallentin, E. Churchill, and D. Mochly-Rosen deltaPKC participates in the endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart J Mol Cell Cardiol 43 2007 420 428
181. L. Qiu, X. Ding, Z. Zhang, and Y.J. Kang Copper is required for cobalt-induced transcriptional activity of hypoxia-inducible factor-1 J Pharmacol Exp Ther 2012 (Published online before print. May 22, 2012). http://dx.doi.org/10.1124/jpet.112.194662
182. B. Radovancevic, B. Vrtovec, E. de Kort, R. Radovancevic, I.D. Gregoric, and O.H. Frazier End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices J Heart Lung Transplant 26 2007 815 818
183. K.M. Regula, K. Ens, and L.A. Kirshenbaum Inducible expression of BNIP3 provokes mitochondrial defects and hypoxia-mediated cell death of ventricular myocytes Circ Res 91 2002 226 231
184. D.M. Roberts, J.B. Kearney, J.H. Johnson, M.P. Rosenberg, R. Kumar, and V.L. Bautch The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation Am J Pathol 164 2004 1531 1535
185. E.A. Rose, A.C. Gelijns, A.J. Moskowitz, D.F. Heitjan, L.W. Stevenson, and W. Dembitsky Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
186. M. Ruzicka, V. Skarda, and F.H. Leenen Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats Circulation 92 1995 3568 3573
187. Y. Sakurai, K. Ohgimoto, Y. Kataoka, N. Yoshida, and M. Shibuya Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice Proc Natl Acad Sci U S A 102 2005 1076 1081
188. S. Salzberg, M. Lachat, G. Zund, E. Oechslin, E.R. Schmid, and M. DeBakey Left ventricular assist device as bridge to heart transplantation - lessons learned with the MicroMed DeBakey axial blood flow pump Eur J Cardiothorac Surg 24 2003 113 118
189. M. Sano, T. Minamino, H. Toko, H. Miyauchi, M. Orimo, and Y. Qin p53-Induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload Nature 446 2007 444 448
190. J.L. Sartoretto, B.Y. Jin, M. Bauer, F.B. Gertler, R. Liao, and T. Michel Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart Am J Physiol Heart Circ Physiol 297 2009 H1697 H1710
191. J.J. Saucerman, and A.D. McCulloch Mechanistic systems models of cell signaling networks: a case study of myocyte adrenergic regulation Prog Biophys Mol Biol 85 2004 261 278
192. K.W. Saupe, M. Spindler, J.C. Hopkins, W. Shen, and J.S. Ingwall Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. Reaction kinetics of the creatine kinase isoenzymes in the intact heart J Biol Chem 275 2000 19742 19746
193. S.A. Scheinin, P. Capek, B. Radovancevic, J.M. Duncan, H.A. McAllister Jr., and O.H. Frazier The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy ASAIO J 38 1992 M271 M274
194. R. Scherz-Shouval, E. Shvets, and Z. Elazar Oxidation as a post-translational modification that regulates autophagy Autophagy 3 2007 371 373
195. R. Scherz-Shouval, E. Shvets, E. Fass, H. Shorer, L. Gil, and Z. Elazar Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4 EMBO J 26 2007 1749 1760
196. J. Schultz Jel, S.A. Witt, B.J. Glascock, M.L. Nieman, P.J. Reiser, and S.L. Nix TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II J Clin Invest 109 2002 787 796
197. D. Sedmera, A.C. Cook, G. Shirali, and T.C. McQuinn Current issues and perspectives in hypoplasia of the left heart Cardiol Young 15 2005 56 72
198. G.L. Semenza HIF-1 and human disease: one highly involved factor Genes Dev 14 2000 1983 1991
199. R. Sethi, Q. Shao, B. Ren, H.K. Saini, N. Takeda, and N.S. Dhalla Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system Mol Cell Biochem 263 2004 11 20
200. A. Severino, M. Campioni, S. Straino, F.N. Salloum, N. Schmidt, and U. Herbrand Identification of protein disulfide isomerase as a cardiomyocyte survival factor in ischemic cardiomyopathy J Am Coll Cardiol 50 2007 1029 1037
201. S.P. Sheehy, S. Huang, and K.K. Parker Time-warped comparison of gene expression in adaptive and maladaptive cardiac hypertrophy Circ Cardiovasc Genet 2 2009 116 124
202. M. Shimamatsu, and H. Toshima Impaired coronary vasodilatory capacity after dipyridamole administration in hypertrophic cardiomyopathy Jpn Heart J 28 1987 387 401
203. N. Shimojo, S. Jesmin, S. Zaedi, T. Otsuki, S. Maeda, and N. Yamaguchi Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy Am J Physiol Heart Circ Physiol 293 2007 H474 H481
204. T. Shintani, and D.J. Klionsky Autophagy in health and disease: a double-edged sword Science 306 2004 990 995
205. I. Shiojima, K. Sato, Y. Izumiya, S. Schiekofer, M. Ito, and R. Liao Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure J Clin Invest 115 2005 2108 2118
206. J.C. Shipp Glucose regulation: role of alpha and beta cells of pancreatic islets J Med Assoc State Ala 31 1961 115 118
207. V.E. Shliakhover, I.I. Zinkovich, A.M. Trankovskii, and S.A. Karakash The copper content of the myocardium in the acute form of ischemic heart disease Vrach Delo 1990 11 13
208. K.G. Shyu, J.Y. Liou, B.W. Wang, W.J. Fang, and H. Chang Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart J Biomed Sci 12 2005 409 420
209. N.G. Smedira, K.J. Hoercher, D.Y. Yoon, J. Rajeswaran, L. Klingman, and R.C. Starling Bridge to transplant experience: factors influencing survival to and after cardiac transplant J Thorac Cardiovasc Surg 139 2010 1295 1305 (1305 e1291-1294)
210. A. Somogyi, E. Ruzicska, A. Blazovics, A. Ver, K. Rosta, and M. Toth Insulin treatment decreases the antioxidant defense mechanism in experimental diabetes Med Sci Monit 11 2005 BR206 BR211
211. Y.H. Song, S. Gehmert, S. Sadat, K. Pinkernell, X. Bai, and N. Matthias VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes Biochem Biophys Res Commun 354 2007 999 1003
212. 2+ content in l-thyroxin induced rat ventricular hypertrophy Acta Pharmacol Sin 29 2008 430 436
213. J.C. Spann, and C. Van Meter Cardiac transplantation Surg Clin North Am 78 1998 679 690
214. D. Stilli, L. Bocchi, R. Berni, M. Zaniboni, F. Cacciani, and C. Chaponnier Correlation of alpha-skeletal actin expression, ventricular fibrosis and heart function with the degree of pressure overload cardiac hypertrophy in rats Exp Physiol 91 2006 571 580
215. M. Strueber, G. O'Driscoll, P. Jansz, A. Khaghani, W.C. Levy, and G.M. Wieselthaler Multicenter evaluation of an intrapericardial left ventricular assist system J Am Coll Cardiol 57 2011 1375 1382
216. H. Su, J. Takagawa, Y. Huang, J. Arakawa-Hoyt, J. Pons, and W. Grossman Additive effect of AAV-mediated angiopoietin-1 and VEGF expression on the therapy of infarcted heart Int J Cardiol 133 2009 191 197
217. L. Suckau, H. Fechner, E. Chemaly, S. Krohn, L. Hadri, and J. Kockskamper Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy Circulation 119 2009 1241 1252
218. M. Sun, M. Chen, F. Dawood, U. Zurawska, J.Y. Li, and T. Parker Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state Circulation 115 2007 1398 1407
219. G. Suzuki, T.C. Lee, J.A. Fallavollita, and J.M. Canty Jr. Adenoviral gene transfer of FGF-5 to hibernating myocardium improves function and stimulates myocytes to hypertrophy and reenter the cell cycle Circ Res 96 2005 767 775
220. S. Takahashi Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy Biol Pharm Bull 34 2011 1785 1788
221. E. Takimoto, H.C. Champion, M. Li, D. Belardi, S. Ren, and E.R. Rodriguez Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy Nat Med 11 2005 214 222
222. K.P. Tamirisa, and D. Mukherjee Gene therapy in cardiovascular diseases Curr Gene Ther 2 2002 427 435
223. K.M. Tang, G.R. Wang, P. Lu, R.H. Karas, M. Aronovitz, and S.P. Heximer Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure Nat Med 9 2003 1506 1512
224. K. Tanimoto, Y. Makino, T. Pereira, and L. Poellinger Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein EMBO J 19 2000 4298 4309
225. Y. Taniyama, M. Ito, K. Sato, C. Kuester, K. Veit, and G. Tremp Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy J Mol Cell Cardiol 38 2005 375 385
226. A.P. Tanno, V.J. das Neves, K.T. Rosa, T.S. Cunha, F.C. Giordano, and C.M. Calil Nandrolone and resistance training induce heart remodeling: role of fetal genes and implications for cardiac pathophysiology Life Sci 89 2011 631 637
227. Z. Tao, B. Chen, X. Tan, Y. Zhao, L. Wang, and T. Zhu Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart Proc Natl Acad Sci U S A 108 2011 2064 2069
228. B.I. Terman, M. Dougher-Vermazen, M.E. Carrion, D. Dimitrov, D.C. Armellino, and D. Gospodarowicz Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor Biochem Biophys Res Commun 187 1992 1579 1586
229. D.J. Thuerauf, M. Marcinko, N. Gude, M. Rubio, M.A. Sussman, and C.C. Glembotski Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes Circ Res 99 2006 275 282
230. D. Tirziu, E. Chorianopoulos, K.L. Moodie, R.T. Palac, Z.W. Zhuang, and M. Tjwa Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice J Clin Invest 117 2007 3188 3197
231. A.M. Tolkovsky Mitophagy Biochim Biophys Acta 1793 2009 1508 1515
232. R.J. Torry, D.M. O'Brien, P.M. Connell, and R.J. Tomanek Dipyridamole-induced capillary growth in normal and hypertrophic hearts Am J Physiol 262 1992 H980 H986
233. J.H. van Berlo, J.W. Elrod, M.M. van den Hoogenhof, A.J. York, B.J. Aronow, and S.A. Duncan The transcription factor GATA-6 regulates pathological cardiac hypertrophy Circ Res 107 2010 1032 1040
234. M. van Bilsen, P.J. Smeets, A.J. Gilde, and G.J. van der Vusse Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc Res 61 2004 218 226
235. D. van Heerden, A. Vosloo, and M. Nikinmaa Effects of short-term copper exposure on gill structure, metallothionein and hypoxia-inducible factor-1alpha (HIF-1alpha) levels in rainbow trout (Oncorhynchus mykiss) Aquat Toxicol 69 2004 271 280
236. E. van Rooij, L.B. Sutherland, J.E. Thatcher, J.M. DiMaio, R.H. Naseem, and W.S. Marshall Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis Proc Natl Acad Sci U S A 105 2008 13027 13032
237. T.L. Vanden Hoek, C. Li, Z. Shao, P.T. Schumacker, and L.B. Becker Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion J Mol Cell Cardiol 29 1997 2571 2583
238. R.W. Vandivier, P.M. Henson, and I.S. Douglas Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease Chest 129 2006 1673 1682
239. R. Vidavalur, S.V. Penumathsa, L. Zhan, M. Thirunavukkarasu, and N. Maulik Sildenafil induces angiogenic response in human coronary arteriolar endothelial cells through the expression of thioredoxin, hemeoxygenase and vascular endothelial growth factor Vascul Pharmacol 45 2006 91 95
240. B. Villari, O.M. Hess, D. Moccetti, G. Vassalli, and H.P. Krayenbuehl Effect of progression of left ventricular hypertrophy on coronary artery dimensions in aortic valve disease J Am Coll Cardiol 20 1992 1073 1079
241. I. Vonder Muhll, P. Liu, and G. Webb Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease Int J Cardiol 97 2004 25 33
242. T. Wallimann, M. Dolder, U. Schlattner, M. Eder, T. Hornemann, and E. O'Gorman Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology Biofactors 8 1998 229 234
243. Q.D. Wang, Y.M. Bohlooly, and P.O. Sjoquist Murine models for the study of congestive heart failure: Implications for understanding molecular mechanisms and for drug discovery J Pharmacol Toxicol Methods 50 2004 163 174
244. C.W. Wang, and D.J. Klionsky The molecular mechanism of autophagy Mol Med 9 2003 65 76
245. L. Wang, J.G. Seidman, and C.E. Seidman Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy Ann Intern Med 152 2010 513 520 (W181)
246. K.T. Weber Monitoring tissue repair and fibrosis from a distance Circulation 96 1997 2488 2492
247. K.L. Weeks, and J.R. McMullen The athlete's heart vs. the failing heart: can signaling explain the two distinct outcomes? Physiology (Bethesda) 26 2011 97 105
248. E.O. Weinberg, F.J. Schoen, D. George, Y. Kagaya, P.S. Douglas, and S.E. Litwin Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis Circulation 90 1994 1410 1422
249. S.M. Weis, and D.A. Cheresh Pathophysiological consequences of VEGF-induced vascular permeability Nature 437 2005 497 504
250. S. Westaby Ventricular assist devices as destination therapy Surg Clin North Am 84 2004 91 123
251. P.O. Wester Trace elements in human myocardial infarction determined by neutron activation analysis Acta Med Scand 178 1965 765 788
252. 14C-labeled substrates in humans J Clin Invest 79 1987 359 366
253. K.K. Witte, N.P. Nikitin, A.C. Parker, S. von Haehling, H.D. Volk, and S.D. Anker The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure Eur Heart J 26 2005 2238 2244
254. J. Wohlschlaeger, K.J. Schmitz, C. Schmid, K.W. Schmid, P. Keul, and A. Takeda Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes Cardiovasc Res 68 2005 376 386
255. K.C. Wollert, B. Fiedler, S. Gambaryan, A. Smolenski, J. Heineke, and E. Butt Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes Hypertension 39 2002 87 92
256. A.H. Wyllie Death from inside out: an overview Philos Trans R Soc Lond B Biol Sci 345 1994 237 241
257. L. Xie, and J.F. Collins Transcriptional regulation of the Menkes copper ATPase (Atp7a) gene by hypoxia-inducible factor (HIF2{alpha}) in intestinal epithelial cells Am J Physiol Cell Physiol 300 2011 C1298 C1305
258. H. Xie, and Y.J. Kang Role of copper in angiogenesis and its medicinal implications Curr Med Chem 16 2009 1304 1314
259. Z. Xie, and D.J. Klionsky Autophagosome formation: core machinery and adaptations Nat Cell Biol 9 2007 1102 1109
260. J. Xu, O.A. Carretero, Y.H. Liu, F. Yang, E.G. Shesely, and N. Oja-Tebbe Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure J Card Fail 10 2004 83 89
261. L. Yan, D.E. Vatner, S.J. Kim, H. Ge, M. Masurekar, and W.H. Massover Autophagy in chronically ischemic myocardium Proc Natl Acad Sci U S A 102 2005 13807 13812
262. X. Yang, and C.L. Cepko Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells J Neurosci 16 1996 6089 6099
263. K.C. Yang, P.Y. Jay, J.R. McMullen, and J.M. Nerbonne Enhanced cardiac PI3Kalpha signalling mitigates arrhythmogenic electrical remodelling in pathological hypertrophy and heart failure Cardiovasc Res 93 2012 252 262
264. J. Yang, L.J. Wu, S. Tashino, S. Onodera, and T. Ikejima Reactive oxygen species and nitric oxide regulate mitochondria-dependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells Free Radic Res 42 2008 492 504
265. H. Yaoita, K. Ogawa, K. Maehara, and Y. Maruyama Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction Cardiovasc Res 45 2000 630 641
266. S. Yitzhaki, C. Huang, W. Liu, Y. Lee, A.B. Gustafsson, and R.M. Mentzer Jr. Autophagy is required for preconditioning by the adenosine A1 receptor-selective agonist CCPA Basic Res Cardiol 104 2009 157 167
267. T. Yoshimori Autophagy: a regulated bulk degradation process inside cells Biochem Biophys Res Commun 313 2004 453 458
268. Y. Yuan, G. Hilliard, T. Ferguson, and D.E. Millhorn Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha J Biol Chem 278 2003 15911 15916
269. Z. Yue, S. Jin, C. Yang, A.J. Levine, and N. Heintz Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor Proc Natl Acad Sci U S A 100 2003 15077 15082
270. A. Zafeiridis, V. Jeevanandam, S.R. Houser, and K.B. Margulies Regression of cellular hypertrophy after left ventricular assist device support Circulation 98 1998 656 662
271. N. Zama, and R. Towns Cardiac copper, magnesium, and zinc in recent and old myocardial infarction Biol Trace Elem Res 10 1986 201 208
272. H. Zeng, H.F. Dvorak, and D. Mukhopadhyay Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways J Biol Chem 276 2001 26969 26979
273. P. Zhang, and U. Mende Regulators of G-protein signaling in the heart and their potential as therapeutic targets Circ Res 109 2011 320 333
274. J. Zhang, and J. Narula Molecular biology of myocardial recovery Surg Clin North Am 84 2004 223 242
275. M. Zhang, E. Takimoto, S. Hsu, D.I. Lee, T. Nagayama, and T. Danner Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5 J Am Coll Cardiol 56 2010 2021 2030
276. M. Zhao, A. Chow, J. Powers, G. Fajardo, and D. Bernstein Microarray analysis of gene expression after transverse aortic constriction in mice Physiol Genomics 19 2004 93 105
277. J. Zhong, R. Basu, D. Guo, F.L. Chow, S. Byrns, and M. Schuster Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction Circulation 122 2010 717 728 (718 pp. following 728)
278. Y. Zhou, K. Bourcy, and Y.J. Kang Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway Cardiovasc Res 84 2009 54 63
279. Y. Zhou, Y. Jiang, and Y.J. Kang Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size J Mol Cell Cardiol 45 2008 106 117
280. Z. Zhou, W.T. Johnson, and Y.J. Kang Regression of copper-deficient heart hypertrophy: reduction in the size of hypertrophic cardiomyocytes J Nutr Biochem 20 2009 621 628
281. L. Zhou, W. Ma, Z. Yang, F. Zhang, L. Lu, and Z. Ding VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways Gene Ther 12 2005 196 202
282. D. Zisa, A. Shabbir, M. Mastri, G. Suzuki, and T. Lee Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells Am J Physiol Regul Integr Comp Physiol 297 2009 R1503 R1515
283. X. Zuo, H. Xie, D. Dong, N. Jiang, H. Zhu, and Y.J. Kang Cytochrome c oxidase is essential for copper-induced regression of cardiomyocyte hypertrophy Cardiovasc Toxicol 10 2010 208 215